MedPath

Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing Intracytoplasmic sperm injection (ICSI ).

Phase 3
Recruiting
Conditions
subfertility
ovarian hyperstimulation
Poly cystic ovarian disease
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Registration Number
ACTRN12613000904774
Lead Sponsor
Eman Elkattan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Subfertile women with polycystic ovarian disease
-serum FSH within normal limits( 1-12IU /l)
-at least 15 follicles or more ,more than 10 mm at the time of HCG administration

Exclusion Criteria

-patients need coasting for high risk of OHSS.
-patients need cycle cancellation.
-severe male infertility requiring testicular sperm extraction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Occurrence of ovarian hyper stimulation which can be diagnosed clinically by patient symptoms accompanied by ultrasonography and laboratory investigation [10 months];The severity of ovarian hyper stimulation which is detected by the need for ascitic drainage and the need for hospitalisation [10 months]
Secondary Outcome Measures
NameTimeMethod
chemical pregnancy rate :Positive (serum BHCG) 14 days following Embryo transfer[10 months];clinical pregnancy rate: positive pregnancy test and positive fetal heart beat by ultrasound after 6 weeks gestaional age[10 months];miscarriage rate: diagnosed by ultrasound /clinically[10 months];ectopic rate :diagnosed by ultrasound /clinically[10 months]
© Copyright 2025. All Rights Reserved by MedPath